<DOC>
	<DOCNO>NCT00001948</DOCNO>
	<brief_summary>This study examine compare health-related quality life degree symptom discomfort two group patient receive intensive drug therapy HIV infection . One group receive continuous treatment entire 88-week study period ; interruption therapy time period . Patients enrol National Institute Allergy Infectious Disease 's trial , `` Immunologic Virologic Studies Intermittent versus Continuous HAART [ highly active antiretroviral therapy ] Treatment HIV Disease , '' may participate study . At periodic interval total 7 time 88-week trial , companion study require participant interrupt continuous therapy group complete follow two questionnaire : 1 . MOS-HIV Health Survey - The patient provide self-assessment physical emotional well . Survey question related ability perform work daily live activity , mood state mind , limitation social activity , ability concentrate , energy level , pain level , general quality life , etc . 2 . Symptom Distress Scale - The patient rate degree symptom distress rank 1 5 agreement statement various physical emotional factor , include appetite , nausea , breathing , cough , pain , insomnia , fatigue , bowel problem , concentration , appearance , outlook . Understanding impact HIV treatment health-related quality life symptom distress may provide information helpful evaluate new treatment approach .</brief_summary>
	<brief_title>A Study Health-Related Quality Life HIV-Infected Patients Undergoing Structured Treatment Interruptions Highly Active Antiretroviral Therapy</brief_title>
	<detailed_description>Because multi-drug regimen know highly active antiretroviral therapy ( HAART ) , HIV infection consider chronic , manageable disease many people United States . However , therapy come complex medication administration regimens numerous side effect distress symptom , may impact significantly person 's health-related quality life ( HR-QOL ) . The purpose study evaluate HR-QOL symptom distress ( degree discomfort specific symptom ) individual participate NIAID protocol , `` Immunologic virologic study intermittent versus continuous HAART treatment HIV disease '' . In study thirty-five subject randomly assign receive continuous HAART therapy 35 subject receive interrupted therapy . In , companion study , HR-QOL symptom distress measure seven time point 88 week protocol . Data analyze use repeat measure multivariate statistical test .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Patients must HIV seropositive man woman least 18 year age enrol NIAID clinical trial , `` Immunologic virologic study intermittent versus continuous HAART treatment HIV disease '' . Patients must able read understand standard English .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2002</verification_date>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>Symptom Distress</keyword>
	<keyword>Immune Function</keyword>
	<keyword>Medication Trial</keyword>
	<keyword>Physical Symptoms</keyword>
</DOC>